Association between circadian and chemotherapeutic cycle effects on plasma concentration of 5‑fluorouracil and the clinical outcome following definitive 5‑fluorouracil/cisplatin‑based chemoradiotherapy in patients with esophageal squamous cell carcinoma-Reference-Cited by-同舟云学术

Association between circadian and chemotherapeutic cycle effects on plasma concentration of 5‑fluorouracil and the clinical outcome following definitive 5‑fluorouracil/cisplatin‑based chemoradiotherapy in patients with esophageal squamous cell carcinoma

Published:2018-10-16 Issue: Volume: Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Kuwahara Akiko¹,Kobuchi Shinji²,Tamura Takao³

Affiliation:

1. School of Pharmacy and Pharmaceutical Sciences, Mukogawa Women's University, Nishinomiya, Hyōgo 663‑8179, Japan

2. Department of Pharmacokinetics, Kyoto Pharmaceutical University, Kyoto 607‑8414, Japan

3. Department of Medical Oncology, Kindai University Nara Hospital, Ikoma, Nara 630‑0293, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A high-throughput UHPLC-MS/MS method for the determination of eight anti-tumor drugs in plasma;Analytical Biochemistry;2023-09

2. Current status and future outlooks on therapeutic drug monitoring of fluorouracil;Expert Opinion on Drug Metabolism & Toxicology;2021-12-02

3. Ultra-performance liquid chromatography-tandem mass spectrometry for simultaneous determination of 12 anti-tumor drugs in human plasma and its application in therapeutic drug monitoring;Journal of Pharmaceutical and Biomedical Analysis;2021-11

4. Overcoming barriers to implementing precision dosing with 5‐fluorouracil and capecitabine;British Journal of Clinical Pharmacology;2021-01-15

5. The association of ABCC5 and ABCC11 polymorphisms with the pharmacokinetics of 5-FU in advanced gastric cancer patients;Clinical and Experimental Health Sciences;2020-09-12